Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Study protocol

Outcome following valve surgery in Australia: development of an enhanced database module

Authors: E. Anne Russell, Christopher M Reid, Warren F Walsh, Alex Brown, Graeme P Maguire

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

Valvular heart disease, including rheumatic heart disease (RHD), is an important cause of heart disease globally. Management of advanced disease can include surgery and other interventions to repair or replace affected valves. This article summarises the methodology of a study that will incorporate enhanced data collection systems to provide additional insights into treatment choice and outcome for advanced valvular disease including that due to RHD.

Methods

An enhanced data collection system will be developed linking an existing Australian cardiac surgery registry to more detailed baseline co-morbidity, medication, echocardiographic and hospital separation data to identify predictors of morbidity and mortality outcome following valve surgery.

Discussion

This project aims to collect and incorporate more detailed information regarding pre and postoperative factors and subsequent morbidity. We will use this to provide additional insights into treatment choice and outcome.
Literature
1.
2.
Bisno A, Butchart E, Ganguly N, Ghebrehiwet T, Lue H, Kaplan E, et al. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation 29 October — 1 November 2001. Geneva: WHO; 2004.
3.
Roberts K, Maguire G, Brown A, Atkinson D, Reményi B, Wheaton G, et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014;129(19):1953–61.CrossRefPubMed
4.
5.
Russell E, Tran L, Baker R, Bennetts J, Brown A, Reid C, et al. Valve surgery for rheumatic heart disease in Australia. BMC Cardiovasc Disord. 2014;14:134.CrossRefPubMedPubMedCentral
6.
Russell E, Tran L, Baker R, Bennetts J, Brown A, Reid C, et al. A review of outcome following valve surgery for rheumatic heart disease in Australia. BMC Cardiovasc Disord. 2015;15:103.CrossRefPubMedPubMedCentral
7.
8.
Russell EA, Baker RA, Bennetts JS, Brown A, Reid CM, Tam R, et al. Case load and valve surgery outcome in Australia. International Journal of Cardiology. 2016
9.
10.
RHDAustralia (ARF/RHD writing group) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Darwin: Menzies School of Health Research; 2012.
11.
Choudhary SK, Talwar S, Dubey B, Chopra A, Saxena A, Kumar AS. Mitral valve repair in a predominantly rheumatic population. Long-term results. Tex Heart Inst J. 2001;28(1):8–15.PubMedPubMedCentral
12.
Gupta A, Gharde P, Kumar AS. Anterior mitral leaflet length: predictor for mitral valve repair in a rheumatic population. Ann Thorac Surg. 2010;90(6):1930–3.CrossRefPubMed
13.
Gometza B, al-Halees Z, Shahid M, Hatle LK, Duran CM. Surgery for rheumatic mitral regurgitation in patients below twenty years of age. An analysis of failures. J Heart Valve Dis. 1996;5(3):294–301.PubMed
14.
Galloway AC, Colvin SB, Baumann FG, Grossi EA, Ribakove GH, Harty S, et al. A comparison of mitral valve reconstruction with mitral valve replacement: intermediate-term results. Ann Thorac Surg. 1989;47(5):655–62.CrossRefPubMed
15.
De Santo LS, Romano G, Della Corte A, Tizzano F, Petraio A, Amarelli C, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg. 2005;130(1):13–9.CrossRefPubMed
16.
Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg. 2000;119(1):53–60.CrossRefPubMed
17.
McLean A, Waters M, Spencer E, Hadfield C. Experience with cardiac valve operations in Cape York Peninsula and the Torres Strait Islands, Australia. Med J Aust. 2007;186(11):560–3.PubMed
18.
Kuwaki K, Kawaharada N, Morishita K, Koyanagi T, Osawa H, Maeda T, et al. Mitral valve repair versus replacement in simultaneous mitral and aortic valve surgery for rheumatic disease. Ann Thorac Surg. 2007;83(2):558–63.CrossRefPubMed
19.
Baskerville CA, Hanrahan BB, Burke AJ, Holwell AJ, Remond MG, Maguire GP. Infective endocarditis and rheumatic heart disease in the north of Australia. Heart Lung Circ. 2012;21(1):36–41.CrossRefPubMed
20.
Bakir I, Onan B, Onan IS, Gul M, Uslu N. Is rheumatic mitral valve repair still a feasible alternative?: indications, technique, and results. Tex Heart Inst J. 2013;40(2):163–9.PubMedPubMedCentral
21.
DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly NE, Cohn LH. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg. 2010;139(1):76–83. discussion -4.CrossRefPubMed
22.
Ho HQ, Nguyen VP, Phan KP, Pham NV. Mitral valve repair with aortic valve replacement in rheumatic heart disease. Asian Cardiovasc Thorac Ann. 2004;12(4):341–5.CrossRefPubMed
23.
Sarralde J, Bernal J, Llorca J, Ponton A, Diez-Solorzano L, Gimenez-Rico J, et al. Repair of rheumatic tricuspid valve disease: predictors of very long-term mortality and reoperation. Ann Thorac Surg. 2010;90(2):503–8.CrossRefPubMed
24.
Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier G, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–8.CrossRefPubMed
25.
26.
Kulik A, Be’dard P, Lam B-K, Rubens FD, Hendry PJ, Masters RG, et al. Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg. 2006;30:485–91.CrossRefPubMed
27.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.CrossRef
28.
Russell E, Maguire G, Bennetts J, Baker R, Reid C, Tran L. The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients. Heart Lung Circ. 2016;25(8):e111.CrossRef
29.
Metadata
Title
Outcome following valve surgery in Australia: development of an enhanced database module
Authors
E. Anne Russell
Christopher M Reid
Warren F Walsh
Alex Brown
Graeme P Maguire
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2002-0

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue

Research article

Identified obstacles and prerequisites in telenurses’ work environment – a modified Delphi study

Research article

What factors contribute to the continued low rates of Indigenous status identification in urban general practice? - A mixed-methods multiple site case study

Research article

Determinants of first-time utilization of long-term care services in the Netherlands: an observational record linkage study

Research article

Managing expectations: cognitive authority and experienced control in complex healthcare processes

Research article

Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

Research article

Contraceptive service provider imposed restrictions to contraceptive access in urban Nigeria